ONK Therapeutics

About:

ONK Therapeutics is an innovative cell therapy organisation.

Website: https://www.onktherapeutics.com/

Top Investors: Cormorant Asset Management, Acorn Bioventures, ALSHC

Description:

ONK Therapeutics is an innovative cell therapy company dedicated to developing the next generation of off-the-shelf, optimally engineered natural killer (NK) cell therapies targeting both hematological malignancies and solid tumors.

Total Funding Amount:

$21.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Barna, Galway, Ireland

Founded Date:

2009-01-01

Contact Email:

info(AT)onktherapeutics.com

Founders:

Michael O'Dwyer, Tony Killarney

Number of Employees:

11-50

Last Funding Date:

2022-01-06

IPO Status:

Private

Industries: